Skip to main content
Top
Published in: Current Pain and Headache Reports 5/2016

01-05-2016 | Other Pain (N Vadivelu and A Kaye, Section Editors)

Current State of Opioid Therapy and Abuse

Authors: Laxmaiah Manchikanti, Adam M. Kaye, Alan D. Kaye

Published in: Current Pain and Headache Reports | Issue 5/2016

Login to get access

Abstract

Currently, there is growing tension between the twin challenges of opioid therapy for chronic pain and adverse consequences of abuse, leading to multiple complications including respiratory failure and death. The recent data from Centers for Disease Control and Prevention (CDC) have shown continued escalation of prescription opioid use with opioid overdose deaths topping all previous estimations. Numerous policy initiatives, advisories, and guidelines have been advanced through the years to control the opioid epidemic. The strategies to prevent opioid abuse and to maintain opioid therapy when medically necessary fall into primary and secondary prevention categories. The primary prevention category is extremely crucial, since it involves education of primary care providers and patients at the starting point of opioid therapy. The education of surgeons and other prescribers is as crucial as the education of primary care physicians.
Literature
1.••
go back to reference Rudd RA, Aleshire N, Zibbell JE, Gladden RM. Increases in drug and opioid overdose deaths—United States, 2000-2014. MMWR Morb Mortal Wkly Rep. 2015;64:1–5. The Morbidity and Mortality Weekly Report (MMWR) from the Centers for Disease Control and Prevention (CDC) provides extensive data on increases in drug and opioid overdose deaths in the United States from 2000 to 2014. The data provides comprehensive information in reference to all aspects of opioid overdose deaths. Rudd RA, Aleshire N, Zibbell JE, Gladden RM. Increases in drug and opioid overdose deaths—United States, 2000-2014. MMWR Morb Mortal Wkly Rep. 2015;64:1–5. The Morbidity and Mortality Weekly Report (MMWR) from the Centers for Disease Control and Prevention (CDC) provides extensive data on increases in drug and opioid overdose deaths in the United States from 2000 to 2014. The data provides comprehensive information in reference to all aspects of opioid overdose deaths.
2.••
go back to reference Dart RC, Surratt HL, Cicero TJ, Parrino MW, Severtson G, Bucher-Bartelson B, et al. Trends in opioid analgesic abuse and mortality in the United States. N Engl J Med. 2015;372:241–8. This manuscript provides trends in opioid analgesic abuse and mortality in the United States with a comprehensive look at multiple issues in increasing opioid prescriptions, abuse patterns, resultant mortality, and interrelationship with heroin addiction. Dart RC, Surratt HL, Cicero TJ, Parrino MW, Severtson G, Bucher-Bartelson B, et al. Trends in opioid analgesic abuse and mortality in the United States. N Engl J Med. 2015;372:241–8. This manuscript provides trends in opioid analgesic abuse and mortality in the United States with a comprehensive look at multiple issues in increasing opioid prescriptions, abuse patterns, resultant mortality, and interrelationship with heroin addiction.
3.•
go back to reference Atluri S, Sudarshan G, Manchikanti L. Assessment of the trends in medical use and misuse of opioid analgesics from 2004 to 2011. Pain Physician. 2014;17:E119–28. This manuscript provides an up-to-date assessment of trends in medical use and misuse of opioid analgesics from 2004 to 2011, with information illustrating the explosive use of opioids, correlating with emergency room admissions for overdoses and deaths. Atluri S, Sudarshan G, Manchikanti L. Assessment of the trends in medical use and misuse of opioid analgesics from 2004 to 2011. Pain Physician. 2014;17:E119–28. This manuscript provides an up-to-date assessment of trends in medical use and misuse of opioid analgesics from 2004 to 2011, with information illustrating the explosive use of opioids, correlating with emergency room admissions for overdoses and deaths.
5.••
go back to reference Kolodny A, Courtwright DT, Hwang CS, Kreiner P, Eadie JL, Clark TW, et al. The prescription opioid and heroin crisis: a public health approach to an epidemic of addiction. Annu Rev Public Health. 2015;36:559–74. This manuscript provides a comprehensive account of the prescription opioid and heroin crisis along with approaches to combat an epidemic of addiction. Kolodny A, Courtwright DT, Hwang CS, Kreiner P, Eadie JL, Clark TW, et al. The prescription opioid and heroin crisis: a public health approach to an epidemic of addiction. Annu Rev Public Health. 2015;36:559–74. This manuscript provides a comprehensive account of the prescription opioid and heroin crisis along with approaches to combat an epidemic of addiction.
6.
go back to reference Hoy D, March L, Woolf A, Blyth F, Brooks P, Smith E, et al. The global burden of neck pain: estimates from the global burden of disease 2010 study. Ann Rheum Dis. 2014;73:1309–15.CrossRefPubMed Hoy D, March L, Woolf A, Blyth F, Brooks P, Smith E, et al. The global burden of neck pain: estimates from the global burden of disease 2010 study. Ann Rheum Dis. 2014;73:1309–15.CrossRefPubMed
7.
go back to reference US Burden of Disease Collaborators. The state of US health, 1999-2010: burden of diseases, injuries, and risk factors. JAMA. 2013;310:591–608.CrossRef US Burden of Disease Collaborators. The state of US health, 1999-2010: burden of diseases, injuries, and risk factors. JAMA. 2013;310:591–608.CrossRef
8.
go back to reference Hoy D, March L, Brooks P, Blyth F, Woolf A, Bain C, et al. The global burden of low back pain: Estimates from the Global Burden of Disease 2010 study. Ann Rheum Dis. 2014;73:968–74.CrossRefPubMed Hoy D, March L, Brooks P, Blyth F, Woolf A, Bain C, et al. The global burden of low back pain: Estimates from the Global Burden of Disease 2010 study. Ann Rheum Dis. 2014;73:968–74.CrossRefPubMed
9.
10.
go back to reference Martin BI, Deyo RA, Mirza SK, Turner JA, Comstock BA, Hollingworth W, Sullivan SD. Expenditures and health status among adults with back and neck problems. JAMA. 2008;299:656-64. Erratum in: JAMA. 2008;299:2630. Martin BI, Deyo RA, Mirza SK, Turner JA, Comstock BA, Hollingworth W, Sullivan SD. Expenditures and health status among adults with back and neck problems. JAMA. 2008;299:656-64. Erratum in: JAMA. 2008;299:2630.
11.
go back to reference Cicero TJ, Ellis MS, Harney J. Shifting patterns of prescription opioid and heroin abuse in the United States. N Engl J Med. 2015;373:1789–90.CrossRefPubMed Cicero TJ, Ellis MS, Harney J. Shifting patterns of prescription opioid and heroin abuse in the United States. N Engl J Med. 2015;373:1789–90.CrossRefPubMed
12.
go back to reference Jones CM, Lurie P, Woodcock J. Addressing prescription opioid overdose: data support a comprehensive policy approach. JAMA. 2014;312:1733–4.CrossRefPubMed Jones CM, Lurie P, Woodcock J. Addressing prescription opioid overdose: data support a comprehensive policy approach. JAMA. 2014;312:1733–4.CrossRefPubMed
13.
go back to reference Wilder CM, Miller SC, Tiffany E, Winhusen T, Winstanley EL, Stein MD. Risk factors for opioid overdose and awareness of overdose risk among veterans prescribed chronic opioids for addiction or pain. J Addict Dis. 2015; [Epub ahead of print]. Wilder CM, Miller SC, Tiffany E, Winhusen T, Winstanley EL, Stein MD. Risk factors for opioid overdose and awareness of overdose risk among veterans prescribed chronic opioids for addiction or pain. J Addict Dis. 2015; [Epub ahead of print].
14.
go back to reference Han B, Compton WM, Jones CM, Cai R. Nonmedical prescription opioid use and use disorders among adults aged 18 through 64 years in the United States, 2003-2013. JAMA. 2015;314:1468–78.CrossRefPubMed Han B, Compton WM, Jones CM, Cai R. Nonmedical prescription opioid use and use disorders among adults aged 18 through 64 years in the United States, 2003-2013. JAMA. 2015;314:1468–78.CrossRefPubMed
15.
go back to reference Werber A, Marschall U, L’hoest H, Hauser W, Moradi B, SChiltenwolf M. Opioid therapy in the treatment of chronic pain conditions in Germany. Pain Physician. 2015;18:E323–31.PubMed Werber A, Marschall U, L’hoest H, Hauser W, Moradi B, SChiltenwolf M. Opioid therapy in the treatment of chronic pain conditions in Germany. Pain Physician. 2015;18:E323–31.PubMed
16.
go back to reference Weisberg DF, Becker WC, Fiellin DA, Stannard C. Prescription opioid misuse in the United States and the United Kingdom: cautionary lessons. Int J Drug Policy. 2014;25:1124–30.CrossRefPubMed Weisberg DF, Becker WC, Fiellin DA, Stannard C. Prescription opioid misuse in the United States and the United Kingdom: cautionary lessons. Int J Drug Policy. 2014;25:1124–30.CrossRefPubMed
17.
go back to reference Murphy Y, Goldner EM, Fischer B. Prescription opioid use, harms and interventions in Canada: a review update of new developments and findings since 2010. Pain Physician. 2015;18:E605–14.PubMed Murphy Y, Goldner EM, Fischer B. Prescription opioid use, harms and interventions in Canada: a review update of new developments and findings since 2010. Pain Physician. 2015;18:E605–14.PubMed
18.•
go back to reference Fischer B, Jones W, Murphy Y, Ialomiteanu A, Rehm J. Recent developments in prescription opioid-related dispensing and harm indicators in Ontario, Canada. Pain Physician. 2015;18:E659–62. This manuscript provides issues related to prescription opioid related dispensing and harms in Ontario, Canada, which seem to parallel the United States. Fischer B, Jones W, Murphy Y, Ialomiteanu A, Rehm J. Recent developments in prescription opioid-related dispensing and harm indicators in Ontario, Canada. Pain Physician. 2015;18:E659–62. This manuscript provides issues related to prescription opioid related dispensing and harms in Ontario, Canada, which seem to parallel the United States.
19.
go back to reference Islam MM, McRae IS, Mazumdar S, Taplin S, McKetin R. Prescription opioid analgesics for pain management in Australia: twenty years of dispensing. Intern Med J. 2015; [Epub ahead of print]. Islam MM, McRae IS, Mazumdar S, Taplin S, McKetin R. Prescription opioid analgesics for pain management in Australia: twenty years of dispensing. Intern Med J. 2015; [Epub ahead of print].
20.••
go back to reference Mehendale AW, Goldman MP, Mehendale RP. Opioid overuse pain syndrome (OOPS): the story of opioids, prometheus unbound. J Opioid Manag. 2013;9:421–38. In this manuscript, the most appropriate term opioid overuse pain syndrome or OOPS has been published to show excessive opioid usage and resultant adverse consequences. Mehendale AW, Goldman MP, Mehendale RP. Opioid overuse pain syndrome (OOPS): the story of opioids, prometheus unbound. J Opioid Manag. 2013;9:421–38. In this manuscript, the most appropriate term opioid overuse pain syndrome or OOPS has been published to show excessive opioid usage and resultant adverse consequences.
21.
go back to reference Davis JM, Severtson SG, Bucher-Bartelson B, Dart RC. Using poison center exposure calls to predict prescription opioid abuse and misuse-related emergency department visits. Pharmacoepidemiol Drug Saf. 2014;23:18–25.CrossRefPubMed Davis JM, Severtson SG, Bucher-Bartelson B, Dart RC. Using poison center exposure calls to predict prescription opioid abuse and misuse-related emergency department visits. Pharmacoepidemiol Drug Saf. 2014;23:18–25.CrossRefPubMed
22.••
go back to reference Chen JH, Humphreys K, Shah NH, Lembke A. Distribution of opioids by different types of Medicare prescribers. JAMA Intern Med. 2015;14:1–3. This manuscript provides distribution of opioids by different types of Medicare prescribers showing detailed data on prescription patterns by various types of physicians discounting the usual philosophy that most prescriptions are given by pain physicians. Chen JH, Humphreys K, Shah NH, Lembke A. Distribution of opioids by different types of Medicare prescribers. JAMA Intern Med. 2015;14:1–3. This manuscript provides distribution of opioids by different types of Medicare prescribers showing detailed data on prescription patterns by various types of physicians discounting the usual philosophy that most prescriptions are given by pain physicians.
24.•
go back to reference Toomey, Kaine Call on GAO to review pain clinics’ narcotics dispensing practices. Gov’t watchdog would also examine quality of treatment, patient outcomes. Washington, D.C. December 23, 2015. Senators Toomey and Kaine call the Government Accountability Office to review pain clinics narcotics dispensing practices, without understanding the common prescription patterns by primary care physicians. Toomey, Kaine Call on GAO to review pain clinics’ narcotics dispensing practices. Gov’t watchdog would also examine quality of treatment, patient outcomes. Washington, D.C. December 23, 2015. Senators Toomey and Kaine call the Government Accountability Office to review pain clinics narcotics dispensing practices, without understanding the common prescription patterns by primary care physicians.
25.
go back to reference Lev R, Petro S, Lee A, Lee O, Lucas J, Castillo EM, et al. Methadone related deaths compared to all prescription related deaths. Forensic Sci Int. 2015;257:347–52.CrossRefPubMed Lev R, Petro S, Lee A, Lee O, Lucas J, Castillo EM, et al. Methadone related deaths compared to all prescription related deaths. Forensic Sci Int. 2015;257:347–52.CrossRefPubMed
26.
go back to reference Sites BD, Beach ML, Davis MA. Increases in the use of prescription opioid analgesics and the lack of improvement in disability metrics among users. Reg Anesth Pain Med. 2014;39:6–12.CrossRefPubMedPubMedCentral Sites BD, Beach ML, Davis MA. Increases in the use of prescription opioid analgesics and the lack of improvement in disability metrics among users. Reg Anesth Pain Med. 2014;39:6–12.CrossRefPubMedPubMedCentral
27.
go back to reference Fischer B, Keates A, Bühringer G, Reimer J, Rehm J. Non-medical use of prescription opioids and prescription opioid-related harms: why so markedly higher in North America compared to the rest of the world? Addiction. 2014;109:177–81.CrossRefPubMed Fischer B, Keates A, Bühringer G, Reimer J, Rehm J. Non-medical use of prescription opioids and prescription opioid-related harms: why so markedly higher in North America compared to the rest of the world? Addiction. 2014;109:177–81.CrossRefPubMed
28.
go back to reference Martins SS, Sampson L, Cerdá M, Galea S. Worldwide prevalence and trends in unintentional drug overdose: a systematic review of the literature. Am J Public Health. 2015;105:e29–49.CrossRefPubMedPubMedCentral Martins SS, Sampson L, Cerdá M, Galea S. Worldwide prevalence and trends in unintentional drug overdose: a systematic review of the literature. Am J Public Health. 2015;105:e29–49.CrossRefPubMedPubMedCentral
29.
go back to reference Agarin T, Trescot AM, Agarin A, Lesanics D, Decastro C. Reducing opioid analgesic deaths in America: what health providers can do. Pain Physician. 2015;18:E307–22.PubMed Agarin T, Trescot AM, Agarin A, Lesanics D, Decastro C. Reducing opioid analgesic deaths in America: what health providers can do. Pain Physician. 2015;18:E307–22.PubMed
30.•
go back to reference Manchikanti L, Atluri S, Hansen H, Benyamin RM, Falco FJE, Helm II S, et al. Opioids in chronic noncancer pain: have we reached a boiling point yet? Pain Physician. 2014;17:E1–10. This manuscript describes philosophically current state of opioid therapy in noncancer pain discussing the reaching of the boiling point and measures to curb opioid abuse. Manchikanti L, Atluri S, Hansen H, Benyamin RM, Falco FJE, Helm II S, et al. Opioids in chronic noncancer pain: have we reached a boiling point yet? Pain Physician. 2014;17:E1–10. This manuscript describes philosophically current state of opioid therapy in noncancer pain discussing the reaching of the boiling point and measures to curb opioid abuse.
31.
go back to reference Compton WM, Boyle M, Wargo E. Prescription opioid abuse: problems and responses. Prev Med. 2015;80:5–9.CrossRefPubMed Compton WM, Boyle M, Wargo E. Prescription opioid abuse: problems and responses. Prev Med. 2015;80:5–9.CrossRefPubMed
32.
go back to reference Manchikanti L, Hirsch JA. Lessons learned in the abuse of pain relief medication: a focus on health care costs. Expert Rev Neurother. 2013;13:527–44.CrossRefPubMed Manchikanti L, Hirsch JA. Lessons learned in the abuse of pain relief medication: a focus on health care costs. Expert Rev Neurother. 2013;13:527–44.CrossRefPubMed
33.
go back to reference Manchikanti L, Atluri S, Candido KD, Boswell MV, Simopoulos TT, Grider JS, et al. Zohydro™ approval by Food and Drug Administration: controversial or frightening? Pain Physician. 2014;17:E437–50.PubMed Manchikanti L, Atluri S, Candido KD, Boswell MV, Simopoulos TT, Grider JS, et al. Zohydro approval by Food and Drug Administration: controversial or frightening? Pain Physician. 2014;17:E437–50.PubMed
34.
go back to reference Manchikanti L, Atluri S, Kaye AM, Kaye AD. Hydrocodone bitartrate for chronic pain. Drugs Today. 2015;51:415–27.CrossRefPubMed Manchikanti L, Atluri S, Kaye AM, Kaye AD. Hydrocodone bitartrate for chronic pain. Drugs Today. 2015;51:415–27.CrossRefPubMed
36.
go back to reference Express Scripts Lab. A nation in pain: focusing on US opioid trends for treatment of short-term and longer term pain. An Express Scripts Report, December 9, 2014. Express Scripts Lab. A nation in pain: focusing on US opioid trends for treatment of short-term and longer term pain. An Express Scripts Report, December 9, 2014.
37.
go back to reference Joranson DE, Ryan KM, Gilson AM, Dahl JL. Trends in medical use and abuse of opioid analgesics. JAMA. 2000;283:1710–4.CrossRefPubMed Joranson DE, Ryan KM, Gilson AM, Dahl JL. Trends in medical use and abuse of opioid analgesics. JAMA. 2000;283:1710–4.CrossRefPubMed
38.
go back to reference Gilson AM, Ryan KM, Joranson DE, Dahl JL. A reassessment of trends in the medical use and abuse of opioid analgesics and implications for diversion control: 1997-2002. J Pain Symptom Manage. 2004;28:176–88.CrossRefPubMed Gilson AM, Ryan KM, Joranson DE, Dahl JL. A reassessment of trends in the medical use and abuse of opioid analgesics and implications for diversion control: 1997-2002. J Pain Symptom Manage. 2004;28:176–88.CrossRefPubMed
40.•
go back to reference Fauber J. Painkiller boom fueled by networking. J Sentinel. February 18, 2012. This article by Fauber uncovers numerous conflicts of interest, confluence of interest which fueled the epidemic of opioid prescriptions with numerous parties involved, which also led for improper guidance for physicians to follow through federation of boards of medical licensure. Fauber J. Painkiller boom fueled by networking. J Sentinel. February 18, 2012. This article by Fauber uncovers numerous conflicts of interest, confluence of interest which fueled the epidemic of opioid prescriptions with numerous parties involved, which also led for improper guidance for physicians to follow through federation of boards of medical licensure.
41.
go back to reference Nuckols TK, Anderson L, Popescu I, Diamant AL, Doyle B, Di Capua P, et al. Opioid prescribing: a systematic review and critical appraisal of guidelines for chronic pain. Ann Intern Med. 2014;160:38–47.PubMed Nuckols TK, Anderson L, Popescu I, Diamant AL, Doyle B, Di Capua P, et al. Opioid prescribing: a systematic review and critical appraisal of guidelines for chronic pain. Ann Intern Med. 2014;160:38–47.PubMed
42.
go back to reference Pedersen L, Fredheim OMS. Opioids for chronic noncancer pain: still no evidence for superiority of sustained-release opioids. Clin Pharmacol Ther. 2015;97:114–5.CrossRefPubMed Pedersen L, Fredheim OMS. Opioids for chronic noncancer pain: still no evidence for superiority of sustained-release opioids. Clin Pharmacol Ther. 2015;97:114–5.CrossRefPubMed
44.
go back to reference Chou R, Turner JA, Devine EB, Hansen RN, Sullivan SD, Blazina I, et al. The effectiveness and risks of long-term opioid therapy for chronic pain: a systematic review for a National Institutes of Health Pathways to Prevention Workshop. Ann Intern Med. 2015;162:276–86.CrossRefPubMed Chou R, Turner JA, Devine EB, Hansen RN, Sullivan SD, Blazina I, et al. The effectiveness and risks of long-term opioid therapy for chronic pain: a systematic review for a National Institutes of Health Pathways to Prevention Workshop. Ann Intern Med. 2015;162:276–86.CrossRefPubMed
46.
go back to reference Thielke SM, Turner JA, Shortreed SM, Saunders K, Leresche L, Campbell CI, et al. Do patient-perceived pros and cons of opioids predict sustained higher-dose use? Clin J Pain. 2014;30:93–101.PubMed Thielke SM, Turner JA, Shortreed SM, Saunders K, Leresche L, Campbell CI, et al. Do patient-perceived pros and cons of opioids predict sustained higher-dose use? Clin J Pain. 2014;30:93–101.PubMed
47.•
go back to reference Manchikanti L, Cash KA, Malla Y, Pampati V, Fellows B. A prospective evaluation of psychotherapeutic and illicit drug use in patients presenting with chronic pain at the time of initial evaluation. Pain Physician. 2013;16:E1–13. This manuscript provides a prospective assessment of patients presenting with chronic pain with assessment of their psychotherapeutic and illicit drug use at the time of initial evaluation. Manchikanti L, Cash KA, Malla Y, Pampati V, Fellows B. A prospective evaluation of psychotherapeutic and illicit drug use in patients presenting with chronic pain at the time of initial evaluation. Pain Physician. 2013;16:E1–13. This manuscript provides a prospective assessment of patients presenting with chronic pain with assessment of their psychotherapeutic and illicit drug use at the time of initial evaluation.
49.
go back to reference Calcaterra SL, YAhashita TE, Min SJ, Keniston A, Frank JW, Binswanger IA. Opioid prescribing at hospital discharge contributes to chronic opioid use. J Gen Intern Med. 2015; [Epub ahead of print]. Calcaterra SL, YAhashita TE, Min SJ, Keniston A, Frank JW, Binswanger IA. Opioid prescribing at hospital discharge contributes to chronic opioid use. J Gen Intern Med. 2015; [Epub ahead of print].
50.
go back to reference Jena AB, Goldman D, Weaver L, Karaca-Mandic P. Opioid prescribing by multiple providers in Medicare: retrospective observational study of insurance claims. BMJ. 2014;348:g1393.CrossRefPubMedPubMedCentral Jena AB, Goldman D, Weaver L, Karaca-Mandic P. Opioid prescribing by multiple providers in Medicare: retrospective observational study of insurance claims. BMJ. 2014;348:g1393.CrossRefPubMedPubMedCentral
51.
go back to reference Morden NE, Munson JC, Colla CH, Skinner JS, Bynum JPW, Zhou W, et al. Prescription opioid use among disabled Medicare beneficiaries: intensity, trends, and regional variation. Med Care. 2014;52:852–9.CrossRefPubMedPubMedCentral Morden NE, Munson JC, Colla CH, Skinner JS, Bynum JPW, Zhou W, et al. Prescription opioid use among disabled Medicare beneficiaries: intensity, trends, and regional variation. Med Care. 2014;52:852–9.CrossRefPubMedPubMedCentral
52.
go back to reference Blake H, Leighton P, van der Walt G, Ravenscroft A. Prescribing opioid analgesics for chronic non-malignant pain in general practice—a survey of attitudes and practice. Br J Pain. 2015;9:225–32.CrossRefPubMedPubMedCentral Blake H, Leighton P, van der Walt G, Ravenscroft A. Prescribing opioid analgesics for chronic non-malignant pain in general practice—a survey of attitudes and practice. Br J Pain. 2015;9:225–32.CrossRefPubMedPubMedCentral
56.
go back to reference Larochelle MR, Liebschutz JM, Zhang F, Ross-Degnan D, Wharam JF. Opioid prescribing after nonfatal overdose and association with repeated overdose: a cohort study opioid prescribing after nonfatal overdose. Ann Intern Med. Published online 29 December 2015. Larochelle MR, Liebschutz JM, Zhang F, Ross-Degnan D, Wharam JF. Opioid prescribing after nonfatal overdose and association with repeated overdose: a cohort study opioid prescribing after nonfatal overdose. Ann Intern Med. Published online 29 December 2015.
57.
go back to reference Strassels SA. Economic burden of prescription opioid misuse and abuse. J Manag Care Pharm. 2009;15:556–62.PubMed Strassels SA. Economic burden of prescription opioid misuse and abuse. J Manag Care Pharm. 2009;15:556–62.PubMed
58.
go back to reference Roxburgh A, Bruno R, Larance B, Burns L. Prescription of opioid analgesics and related harms in Australia. Med J Aust. 2011;195:280–4.CrossRefPubMed Roxburgh A, Bruno R, Larance B, Burns L. Prescription of opioid analgesics and related harms in Australia. Med J Aust. 2011;195:280–4.CrossRefPubMed
59.
go back to reference CDC. Vital signs: overdoses of prescription opioid pain relievers and other drugs among women—United States, 1999-2010. MMWR. 2013;62:537–42. CDC. Vital signs: overdoses of prescription opioid pain relievers and other drugs among women—United States, 1999-2010. MMWR. 2013;62:537–42.
60.
go back to reference Slevin KA, Ashburn MA. Primary care physician opinion survey on FDA opioid risk evaluation and mitigation strategies. J Opioid Manag. 2011;7:109–15.PubMed Slevin KA, Ashburn MA. Primary care physician opinion survey on FDA opioid risk evaluation and mitigation strategies. J Opioid Manag. 2011;7:109–15.PubMed
61.
go back to reference Degenhardt L, Hall W. Extent of illicit drug use and dependence, and their contribution to the global burden of disease. Lancet. 2012;379:55–70.CrossRefPubMed Degenhardt L, Hall W. Extent of illicit drug use and dependence, and their contribution to the global burden of disease. Lancet. 2012;379:55–70.CrossRefPubMed
63.
go back to reference Angres DH, Bettinardi-Angres K. The disease of addiction: origins, treatment, and recovery. Dis Mon. 2008;54:696–721.CrossRefPubMed Angres DH, Bettinardi-Angres K. The disease of addiction: origins, treatment, and recovery. Dis Mon. 2008;54:696–721.CrossRefPubMed
64.
go back to reference Upadhyay J, Maleki N, Potter J, Elman I, Rudrauf D, Knudsen J, et al. Alterations in brain structure and functional connectivity in prescription opioid-dependent patients. Brain. 2010;133:2098–114.CrossRefPubMedPubMedCentral Upadhyay J, Maleki N, Potter J, Elman I, Rudrauf D, Knudsen J, et al. Alterations in brain structure and functional connectivity in prescription opioid-dependent patients. Brain. 2010;133:2098–114.CrossRefPubMedPubMedCentral
65.
go back to reference Younger JW, Chu LF, D’Arcy NT, Trott KE, Jastrzab LE, Mackey SC. Prescription opioid analgesics rapidly change the human brain. Pain. 2011;152:1803–10.CrossRefPubMedPubMedCentral Younger JW, Chu LF, D’Arcy NT, Trott KE, Jastrzab LE, Mackey SC. Prescription opioid analgesics rapidly change the human brain. Pain. 2011;152:1803–10.CrossRefPubMedPubMedCentral
66.
go back to reference Portenoy RK, Foley KM. Chronic use of opioid analgesics in non-malignant pain: report of 38 cases. Pain. 1986;25:171–86.CrossRefPubMed Portenoy RK, Foley KM. Chronic use of opioid analgesics in non-malignant pain: report of 38 cases. Pain. 1986;25:171–86.CrossRefPubMed
67.
go back to reference Hser YI, Hoffman V, Grella CE, Anglin MD. A 33-year follow-up of narcotics addicts. Arch Gen Psychiatry. 2001;58:503–8.CrossRefPubMed Hser YI, Hoffman V, Grella CE, Anglin MD. A 33-year follow-up of narcotics addicts. Arch Gen Psychiatry. 2001;58:503–8.CrossRefPubMed
68.
69.
go back to reference Chou R, Cruciani RA, Fiellin DA, Compton P, Farrar JT, Haigney MC, et al. Methadone safety: a clinical practice guideline from the American Pain Society and College on Problems of Drug Dependence, in collaboration with the Heart Rhythm Society. J Pain. 2014;15:321–37.CrossRefPubMed Chou R, Cruciani RA, Fiellin DA, Compton P, Farrar JT, Haigney MC, et al. Methadone safety: a clinical practice guideline from the American Pain Society and College on Problems of Drug Dependence, in collaboration with the Heart Rhythm Society. J Pain. 2014;15:321–37.CrossRefPubMed
70.
go back to reference Weimer MB, Chou R. Research gaps on methadone harms and comparative harms: findings from a review of the evidence for an American Pain Society and College on Problems of Drug Dependence clinical practice guideline. J Pain. 2014;15:366–76.CrossRefPubMed Weimer MB, Chou R. Research gaps on methadone harms and comparative harms: findings from a review of the evidence for an American Pain Society and College on Problems of Drug Dependence clinical practice guideline. J Pain. 2014;15:366–76.CrossRefPubMed
71.
go back to reference Price LC, Wobeter B, Delate T, Kurz D, Shanahan R. Methadone for pain and the risk of adverse cardiac outcomes. J Pain Symptom Manage. 2014;48:333–42.e1.CrossRefPubMed Price LC, Wobeter B, Delate T, Kurz D, Shanahan R. Methadone for pain and the risk of adverse cardiac outcomes. J Pain Symptom Manage. 2014;48:333–42.e1.CrossRefPubMed
72.
go back to reference Manchikanti L, Whitfield E, Pallone F. Evolution of the National All Schedules Prescription Electronic Reporting Act (NASPER): a public law for balancing treatment of pain and drug abuse and diversion. Pain Physician. 2005;8:335–47.PubMed Manchikanti L, Whitfield E, Pallone F. Evolution of the National All Schedules Prescription Electronic Reporting Act (NASPER): a public law for balancing treatment of pain and drug abuse and diversion. Pain Physician. 2005;8:335–47.PubMed
74.
go back to reference Garcia AM. State laws regulating prescribing of controlled substances: balancing the public health problems of chronic pain and prescription painkiller abuse and overdose. J Med Ethics. 2013;41 Suppl 1:42–5.CrossRef Garcia AM. State laws regulating prescribing of controlled substances: balancing the public health problems of chronic pain and prescription painkiller abuse and overdose. J Med Ethics. 2013;41 Suppl 1:42–5.CrossRef
75.
go back to reference Cheatle MD. Prescription opioid misuse, abuse, morbidity, and mortality: balancing effective pain management and safety. Pain Med. 2015;16 Suppl 1:S3–8.CrossRefPubMed Cheatle MD. Prescription opioid misuse, abuse, morbidity, and mortality: balancing effective pain management and safety. Pain Med. 2015;16 Suppl 1:S3–8.CrossRefPubMed
76.
go back to reference Cohen V, Motov S, Rockoff B, Smith A, Fromm C, Hossain R, et al. Development of an opioid reduction protocol in an emergency department. Am J Health Syst Pharm. 2015;72:2080–6.CrossRefPubMed Cohen V, Motov S, Rockoff B, Smith A, Fromm C, Hossain R, et al. Development of an opioid reduction protocol in an emergency department. Am J Health Syst Pharm. 2015;72:2080–6.CrossRefPubMed
77.
go back to reference Ballantyne JC, Sullivan MD, Kolodny A. Opioid dependence vs addiction: a distinction without a difference? Arch Intern Med. 2012;172:1342–3.CrossRefPubMed Ballantyne JC, Sullivan MD, Kolodny A. Opioid dependence vs addiction: a distinction without a difference? Arch Intern Med. 2012;172:1342–3.CrossRefPubMed
79.
go back to reference Fulton-Kehoe D, Sullivan MD, Turner JA, Garg RK, Bauer AM, Wickizer TM, et al. Opioid poisonings in Washington State Medicaid: trends, dosing, and guidelines. Med Care. 2015;53:679–85.CrossRefPubMed Fulton-Kehoe D, Sullivan MD, Turner JA, Garg RK, Bauer AM, Wickizer TM, et al. Opioid poisonings in Washington State Medicaid: trends, dosing, and guidelines. Med Care. 2015;53:679–85.CrossRefPubMed
80.
go back to reference Sheperd J. Combating the prescription painkiller epidemic: a national prescription drug reporting program. Am J Law Med. 2014;40:85–112. Sheperd J. Combating the prescription painkiller epidemic: a national prescription drug reporting program. Am J Law Med. 2014;40:85–112.
81.
go back to reference Griggs CA, Weiner SG, Feldman JA. Prescription drug monitoring programs: examining limitations and future approaches. West J Emerg Med. 2015;16:67–70.CrossRefPubMedPubMedCentral Griggs CA, Weiner SG, Feldman JA. Prescription drug monitoring programs: examining limitations and future approaches. West J Emerg Med. 2015;16:67–70.CrossRefPubMedPubMedCentral
82.
go back to reference Islam MM, McRae IS. An inevitable wave of prescription drug monitoring programs in the context of prescription opioids: pros, cons and tensions. BMC Pharmacol Toxicol. 2014;15:46.CrossRefPubMedPubMedCentral Islam MM, McRae IS. An inevitable wave of prescription drug monitoring programs in the context of prescription opioids: pros, cons and tensions. BMC Pharmacol Toxicol. 2014;15:46.CrossRefPubMedPubMedCentral
83.
go back to reference Starrels JL, Becker WC, Alford DP, Kapoor A, Williams AR, Turner BJ. Systematic review: treatment agreements and urine drug testing to reduce opioid misuse in patients with chronic pain. Ann Intern Med. 2010;152:712–20.CrossRefPubMed Starrels JL, Becker WC, Alford DP, Kapoor A, Williams AR, Turner BJ. Systematic review: treatment agreements and urine drug testing to reduce opioid misuse in patients with chronic pain. Ann Intern Med. 2010;152:712–20.CrossRefPubMed
84.
go back to reference Nguyen V, Raffa RB, Taylor R, Pergolizzi JV. The role of abuse-deterrent formulations in countering opioid misuse and abuse. J Clin Pharm Ther. 2015; [Epub ahead of print]. Nguyen V, Raffa RB, Taylor R, Pergolizzi JV. The role of abuse-deterrent formulations in countering opioid misuse and abuse. J Clin Pharm Ther. 2015; [Epub ahead of print].
85.
go back to reference Leece P, Orkin AM, Kahan M. Tamper-resistant drugs cannot solve the opioid crisis. CMAJ. 2015;187:717–8.CrossRefPubMed Leece P, Orkin AM, Kahan M. Tamper-resistant drugs cannot solve the opioid crisis. CMAJ. 2015;187:717–8.CrossRefPubMed
86.
go back to reference Larochelle MR, Zhang F, Ross-Degnan D, Wharam JF. Rates of opioid dispensing and overdose after introduction of abuse-deterrent extended-release oxycodone and withdrawal of propoxyphene. JAMA Intern Med. 2015;175:978–87.CrossRefPubMed Larochelle MR, Zhang F, Ross-Degnan D, Wharam JF. Rates of opioid dispensing and overdose after introduction of abuse-deterrent extended-release oxycodone and withdrawal of propoxyphene. JAMA Intern Med. 2015;175:978–87.CrossRefPubMed
87.
go back to reference Clark AK, Wilder CM, Winstanley EL. A systematic review of community opioid overdose prevention and naloxone distribution programs. J Addict Med. 2014;8:153–63.CrossRefPubMed Clark AK, Wilder CM, Winstanley EL. A systematic review of community opioid overdose prevention and naloxone distribution programs. J Addict Med. 2014;8:153–63.CrossRefPubMed
88.
go back to reference Conermann T, Gosalia AR, Kabazie AJ, Moore C, Miller K, Fetsch M, et al. Utility of oral fluid in compliance monitoring of opioid medications. Pain Physician. 2014;17:63–70.PubMed Conermann T, Gosalia AR, Kabazie AJ, Moore C, Miller K, Fetsch M, et al. Utility of oral fluid in compliance monitoring of opioid medications. Pain Physician. 2014;17:63–70.PubMed
90.
go back to reference Courtwright DT. Preventing and treating narcotic addiction—century of federal drug control. N Engl J Med. 2015;373:2095–7.CrossRefPubMed Courtwright DT. Preventing and treating narcotic addiction—century of federal drug control. N Engl J Med. 2015;373:2095–7.CrossRefPubMed
91.
go back to reference Gasior M, Bond M, Malamut R. Routes of abuse of prescription opioid analgesics: a review and assessment of the potential impact of abuse-deterrent formulations. Postgrad Med. 2015 Dec 18:1-12. [Epub ahead of print]. Gasior M, Bond M, Malamut R. Routes of abuse of prescription opioid analgesics: a review and assessment of the potential impact of abuse-deterrent formulations. Postgrad Med. 2015 Dec 18:1-12. [Epub ahead of print].
92.
go back to reference Turner JA, Saunders K, Shortreed SM, Rapp SE, Thielke S, LeResche L, et al. Chronic opioid therapy risk reduction initiative: impact on urine drug testing rates and results. J Gen Intern Med. 2014;29:305–11.CrossRefPubMedPubMedCentral Turner JA, Saunders K, Shortreed SM, Rapp SE, Thielke S, LeResche L, et al. Chronic opioid therapy risk reduction initiative: impact on urine drug testing rates and results. J Gen Intern Med. 2014;29:305–11.CrossRefPubMedPubMedCentral
93.
go back to reference Garcia MM, Angelini MC, Thomas T, Lenz K, Jeffrey P. Implementation of an opioid management initiative by a state Medicaid program. J Manag Care Spec Pharm. 2014;20:447–54.PubMed Garcia MM, Angelini MC, Thomas T, Lenz K, Jeffrey P. Implementation of an opioid management initiative by a state Medicaid program. J Manag Care Spec Pharm. 2014;20:447–54.PubMed
94.
go back to reference Bird SM, McAuley A, Perry S, Hunter C. Effectiveness of Scotland’s national naloxone programme for reducing opioid-related deaths: a before (2006-10) versus after (2011-13) comparison. Addiction. 2015; [Epub ahead of print]. Bird SM, McAuley A, Perry S, Hunter C. Effectiveness of Scotland’s national naloxone programme for reducing opioid-related deaths: a before (2006-10) versus after (2011-13) comparison. Addiction. 2015; [Epub ahead of print].
95.
go back to reference Paulozzi LJ, Strickler GK, Kreiner PW, Koris CM. Controlled substance prescribing patterns—prescription behavior surveillance system, eight states, 2013. MMWR Surveill Summ. 2015;64:1–14.CrossRefPubMed Paulozzi LJ, Strickler GK, Kreiner PW, Koris CM. Controlled substance prescribing patterns—prescription behavior surveillance system, eight states, 2013. MMWR Surveill Summ. 2015;64:1–14.CrossRefPubMed
97.
go back to reference Manchikanti L, Manchukonda R, Damron KS, Brandon D, McManus CD, Cash KA. Does adherence monitoring reduce controlled substance abuse in chronic pain patients? Pain Physician. 2006;9:57–60.PubMed Manchikanti L, Manchukonda R, Damron KS, Brandon D, McManus CD, Cash KA. Does adherence monitoring reduce controlled substance abuse in chronic pain patients? Pain Physician. 2006;9:57–60.PubMed
99.
go back to reference Cappola AR, FitzGerald GA. Confluence, not conflict of interest: name change necessary. JAMA. 2015;314:1791–2.CrossRefPubMed Cappola AR, FitzGerald GA. Confluence, not conflict of interest: name change necessary. JAMA. 2015;314:1791–2.CrossRefPubMed
100.
go back to reference Manchikanti L, Benyamin RM, Falco FJE, Caraway DL, Datta S, Hirsch JA. Guidelines warfare over interventional techniques: is there a lack of discourse or straw man? Pain Physician. 2012;15:E1–26.PubMed Manchikanti L, Benyamin RM, Falco FJE, Caraway DL, Datta S, Hirsch JA. Guidelines warfare over interventional techniques: is there a lack of discourse or straw man? Pain Physician. 2012;15:E1–26.PubMed
101.
go back to reference Krasselt M, Häuser W, Petzke F, Baerwald C. S3 guidelines on long-term opioid treatment in non-cancer pain: recommendations for opioid use in clinical rheumatology. Z Rheumatol. 2015; [Epub ahead of print]. Krasselt M, Häuser W, Petzke F, Baerwald C. S3 guidelines on long-term opioid treatment in non-cancer pain: recommendations for opioid use in clinical rheumatology. Z Rheumatol. 2015; [Epub ahead of print].
Metadata
Title
Current State of Opioid Therapy and Abuse
Authors
Laxmaiah Manchikanti
Adam M. Kaye
Alan D. Kaye
Publication date
01-05-2016
Publisher
Springer US
Published in
Current Pain and Headache Reports / Issue 5/2016
Print ISSN: 1531-3433
Electronic ISSN: 1534-3081
DOI
https://doi.org/10.1007/s11916-016-0564-x

Other articles of this Issue 5/2016

Current Pain and Headache Reports 5/2016 Go to the issue

Uncommon and/or Unusual Headaches and Syndromes (J Ailani, Section Editor)

Ice Pick Headache

Other Pain (N Vadivelu and A Kaye, Section Editors)

Pain Control in the Presence of Drug Addiction

Uncommon and/or Unusual Headaches and Syndromes (J Ailani, Section Editor)

No Laughing Matter: Gelastic Migraine and Other Unusual Headache Syndromes

Other Pain (N Vadivelu and A Kaye, Section Editors)

Role of Alternative Therapies for Chronic Pain Syndromes

Other Pain (N Vadivelu and A Kaye, Section Editors)

New Chronic Pain Treatments in the Outpatient Setting: Review Article

Childhood and Adolescent Headache (S Evers, Section Editor)

The Link Between Infantile Colic and Migraine